Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

8(80.0%)

Phase 3

1(10.0%)

Phase 2

1(10.0%)

10Total

N/A(8)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06671613Not ApplicableRecruiting

Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer

Role: collaborator

NCT05921149Not ApplicableNot Yet Recruiting

Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer

Role: collaborator

NCT06376604Not ApplicableRecruiting

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

Role: lead

NCT04499599Not ApplicableCompleted

Effects of Fast Bar on Physiological Fasting

Role: lead

NCT06115551Not ApplicableActive Not Recruiting

Fasting Mimicking Diet and Autophagy

Role: lead

NCT05503108Phase 3Suspended

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

Role: collaborator

NCT05564624Not ApplicableCompleted

Effect of Fasting-Mimicking Diet on Skin Health

Role: lead

NCT04790552Not ApplicableCompleted

Effects of Fast Bar on Intermittent Fasting

Role: lead

NCT04962464Phase 2Unknown

The Impact of a Fast Diet and Calorie Mimetic Supplements on Epigenetic Aging

Role: collaborator

NCT04150159Not ApplicableCompleted

Evaluation of a Fasting Mimicking Diet

Role: collaborator

All 10 trials loaded